351 related articles for article (PubMed ID: 34115763)
1. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.
Borse S; Joshi M; Saggam A; Bhat V; Walia S; Marathe A; Sagar S; Chavan-Gautam P; Girme A; Hingorani L; Tillu G
PLoS One; 2021; 16(6):e0248479. PubMed ID: 34115763
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of phytoconstituents of
Choudhary P; Singh T; Amod A; Singh S
J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
[TBL] [Abstract][Full Text] [Related]
4. The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review.
Adithya J; Nair B; Aishwarya TS; Nath LR
Curr Pharm Biotechnol; 2021; 22(7):906-919. PubMed ID: 32767920
[TBL] [Abstract][Full Text] [Related]
5. Exploring nature's bounty: identification of
Srivastava A; Siddiqui S; Ahmad R; Mehrotra S; Ahmad B; Srivastava AN
J Biomol Struct Dyn; 2022 Mar; 40(4):1858-1908. PubMed ID: 33246398
[TBL] [Abstract][Full Text] [Related]
6. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological potential of
Rizvi ZA; Babele P; Madan U; Sadhu S; Tripathy MR; Goswami S; Mani S; Dikshit M; Awasthi A
Front Immunol; 2023; 14():1138215. PubMed ID: 36960064
[TBL] [Abstract][Full Text] [Related]
8. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
Ghosh A; Chakraborty M; Chandra A; Alam MP
J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
[TBL] [Abstract][Full Text] [Related]
11. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
Salpini R; Alkhatib M; Costa G; Piermatteo L; Ambrosio FA; Di Maio VC; Scutari R; Duca L; Berno G; Fabeni L; Alcaro S; Ceccherini-Silberstein F; Artese A; Svicher V
J Antimicrob Chemother; 2021 Jan; 76(2):396-412. PubMed ID: 33254234
[TBL] [Abstract][Full Text] [Related]
12. An Insight of Clinical Evidence of Ayurveda Interventions in the Management of COVID-19 Patients.
Maideen NMP; Balasubramanian R; Manavalan G; Balasubramanian K; Subramanian N; Murugesan T; Solaimalai VK
Infect Disord Drug Targets; 2022; 22(6):e210322202491. PubMed ID: 35319399
[TBL] [Abstract][Full Text] [Related]
13. Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study.
Abdelaal Ahmed Mahmoud M Alkhatip A; Georgakis M; Montero Valenzuela LR; Hamza M; Farag E; Hodgkinson J; Hosny H; Kamal AM; Wagih M; Naguib A; Yassin H; Algameel H; Elayashy M; Abdelhaq M; Younis MI; Mohamed H; Abdulshafi M; Elramely MA
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804129
[TBL] [Abstract][Full Text] [Related]
14. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.
Singh SK; Singh S; Singh R
J Ovarian Res; 2021 Sep; 14(1):126. PubMed ID: 34579761
[TBL] [Abstract][Full Text] [Related]
15. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
16. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an
Trivedi A; Ahmad R; Siddiqui S; Misra A; Khan MA; Srivastava A; Ahamad T; Khan MF; Siddiqi Z; Afrin G; Gupta A; Upadhyay S; Husain I; Ahmad B; Mehrotra S; Kant S
J Biomol Struct Dyn; 2022; 40(20):9648-9700. PubMed ID: 34243689
[TBL] [Abstract][Full Text] [Related]
18. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
19. Effect of botanical immunomodulators on human CYP3A4 inhibition: implications for concurrent use as adjuvants in cancer therapy.
Patil D; Gautam M; Gairola S; Jadhav S; Patwardhan B
Integr Cancer Ther; 2014 Mar; 13(2):167-75. PubMed ID: 24105360
[TBL] [Abstract][Full Text] [Related]
20. In silico investigation of phytoconstituents from Indian medicinal herb '
Chowdhury P
J Biomol Struct Dyn; 2021 Oct; 39(17):6792-6809. PubMed ID: 32762511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
